Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Roberts

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
British Journal of Haematology|May 4, 2017
The use of Imatinib resistance mutation analysis to direct therapy in Philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukaemia patients failing Imatinib treatment, in Patan Hospital, NepalGyan K Kayastha, Nora Ranjitkar, Radha Gurung, et al.
The Journal of Biological Chemistry|July 23, 2015
Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)Cathryn Weston, Jing Lu, Naichang Li, et al.
The Cochrane Database of Systematic Reviews|May 12, 2026
Convalescent plasma for people with COVID-19Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
JCI Insight|February 15, 2017
Foxp3 drives oxidative phosphorylation and protection from lipotoxicityDuncan Howie, Stephen Paul Cobbold, Elizabeth Adams, et al.
The Cochrane Database of Systematic Reviews|January 26, 2023
Hyperimmune immunoglobulin for people with COVID-19Catherine Kimber, Sarah J Valk, Khai Li Chai, et al.
The Cochrane Database of Systematic Reviews|October 12, 2020
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic reviewKhai Li Chai, Sarah J Valk, Vanessa Piechotta, et al.
Transfusion Medicine (Oxford, England)|January 10, 2020
Transfusion-transmitted hepatitis C: A cluster of cases in transfusion-dependent thalassaemia patients in Sri LankaShiromi Perera, David Bonsall, Madunil A Niriella, et al.
British Journal of Haematology|April 4, 2017
Treating Philadelphia chromosome/BCR-ABL1 positive patients with Glivec (Imatinib mesylate): 10 years' experience at Patan Hospital, NepalGyan K Kayastha, Nora Ranjitkar, Radha Gurung, et al.
Scientific Reports|March 2, 2022
Publisher Correction: Abnormal whole-body energy metabolism in iron-deficient humans despite preserved skeletal muscle oxidative phosphorylationMatthew C Frise, David A Holdsworth, Andrew W Johnson, et al.
Trials|September 21, 2016
Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervalsCarmel Moore, Thomas Bolton, Matthew Walker, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
British Journal of Haematology|May 4, 2017
The use of Imatinib resistance mutation analysis to direct therapy in Philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukaemia patients failing Imatinib treatment, in Patan Hospital, NepalGyan K Kayastha, Nora Ranjitkar, Radha Gurung, et al.
The Journal of Biological Chemistry|July 23, 2015
Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)Cathryn Weston, Jing Lu, Naichang Li, et al.
The Cochrane Database of Systematic Reviews|May 12, 2026
Convalescent plasma for people with COVID-19Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
JCI Insight|February 15, 2017
Foxp3 drives oxidative phosphorylation and protection from lipotoxicityDuncan Howie, Stephen Paul Cobbold, Elizabeth Adams, et al.
The Cochrane Database of Systematic Reviews|January 26, 2023
Hyperimmune immunoglobulin for people with COVID-19Catherine Kimber, Sarah J Valk, Khai Li Chai, et al.
The Cochrane Database of Systematic Reviews|October 12, 2020
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic reviewKhai Li Chai, Sarah J Valk, Vanessa Piechotta, et al.
Transfusion Medicine (Oxford, England)|January 10, 2020
Transfusion-transmitted hepatitis C: A cluster of cases in transfusion-dependent thalassaemia patients in Sri LankaShiromi Perera, David Bonsall, Madunil A Niriella, et al.
British Journal of Haematology|April 4, 2017
Treating Philadelphia chromosome/BCR-ABL1 positive patients with Glivec (Imatinib mesylate): 10 years' experience at Patan Hospital, NepalGyan K Kayastha, Nora Ranjitkar, Radha Gurung, et al.
Scientific Reports|March 2, 2022
Publisher Correction: Abnormal whole-body energy metabolism in iron-deficient humans despite preserved skeletal muscle oxidative phosphorylationMatthew C Frise, David A Holdsworth, Andrew W Johnson, et al.
Trials|September 21, 2016
Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervalsCarmel Moore, Thomas Bolton, Matthew Walker, et al.
Pageof 23